Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06050304Recruiting
Open-label, single-arm trial in cocaine use disorder (CUD), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Reduction in sleep duration on crack-cocaine use days following a break of at least 2 days compared to crack-cocaine use days without any break. Started Mar 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06050304.